Skip to content

Clinical effect of initial periodontal treatment combined with immunosuppressant on erosive oral lichen planus

Clinical effect of initial periodontal treatment combined with immunosuppressant on erosive oral lichen planus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014297
Enrollment
Unknown
Registered
2018-01-04
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

erosive oral lichen planus

Interventions

initial periodontal treatment combined with immunosuppressant group:initial periodontal treatment combined with immunosuppressant for the treatment of oral lichen planus
immunosuppressant group:immunosuppressant for the treatment of oral lichen planus

Sponsors

Department of Periodontology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, National C
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-65 years old; 2. Oral lesions confined to the gums or gingival groove and other parts, generally symmetrical, white or gray-white papules, plaques, mesh, ring type, which can be accompanied by hyperemia, erosions, vesicular lesions; at the same time or separately in the skin, finger (toe) a part of the damage, skin damage to purple-red polygonal flat papules, finger (toe) in a thumb, deck atrophy thinning and dull, there are serious fissure formation; 3. Pathologically excessive orthokeratinized epithelial hyperkeratosis or not, spinous layer hyperplasia or atrophy, liquefaction degeneration of the basal cell layer, lamina propria lymphocyte infiltration strip; 4. Clinical damage of oral lichen planus score the first diagnosis fraction more than 5 points.

Exclusion criteria

Exclusion criteria: 1. any history of systemic disease (e.g., diabetes, hypertension, cardiovascular disease); 2. use any of Antibiotics, hormones or immunomodulators 3 months before; 3. subjects who with any other mucosal diseases in the mouth; 4. a history of allergies to immunosuppressants or regulators; 5. subjects who had received periodontal treatment within the last 6 months.

Design outcomes

Primary

MeasureTime frame
Clinical damage score of oral lichen plants on gingiva;

Secondary

MeasureTime frame
Visual analogue scale;Probing depth;Loss of attachment;Bleeding on probing index;

Countries

China

Contacts

Public ContactSong Zhongchen

Department of Periodontology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, National C

szhongchen@sina.com+86 13761158169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026